Projects per year
Personal profile
About
Lauren Carcas, M.D., is a medical oncologist who specializes in breast cancer. She serves as a patient’s primary cancer care physician, diagnosing and staging the disease as well as treating it using chemotherapy, hormonal therapy, biological therapy and targeted therapy. She monitors a patient’s progress, provides supportive care and coordinates treatment provided by other specialists. Dr. Carcas also has extensive training and research experience in the management of other solid malignancies, including lung, colorectal, prostate, bladder, kidney, skin and pancreas, as well as both malignant and benign hematologic conditions. She has conducted numerous clinical trials, most notably in breast cancer, to improve care and outcomes for cancer patients. She has published her clinical results in medical journals and presented at symposiums. She is a member of several professional societies, including the American Society of Clinical Oncology, American Society of Hematology and American College of Physicians. She is fluent in English and Spanish.
Related documents
Education/Academic qualification
Fellowship Program - Hematology/Oncology, Jackson Memorial Hospital/University of Miami
2011 → 2014
Residency Program - Internal Medicine, Jackson Memorial Hospital/University of Miami
2007 → 2010
Miller School of Medicine, Doctor of Medicine, M.D., University of Miami
2002 → 2006
Spanish, B.A., Samford University
1997 → 2001
International Relations, B.A., Samford University
1997 → 2001
External positions
Medical Oncologist, Florida Cancer Care & Florida Cancer Research Institute, LLC.
Sep 1 2014 → Dec 1 2017
Physician, Home Hospice Care, VITAS Innovative Hospice Care
Jul 1 2010 → Sep 1 2014
Chief Medical Resident, Instructor of Medicine, University of Miami
Jun 1 2010 → Jun 1 2011
Instructor of Medicine, University of Miami
Jan 1 2010 → Jan 1 2011
Disciplines
- Medicine and Health Sciences
- Oncology
-
A Phase III Double-blind Randomized Study Assessing the Efficacy and Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line Treatment for Patients with Histologically Confirmed, Locally Advanced (Inoperable) or Metastatic Triple Negative Breast Cancer (TNBC)
Carcas, L. (PI)
1/1/19 → …
Project: Research project
-
MammaPrint, BluePrint, and Full-Genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles (FLEX)
Carcas, L. (PI)
1/1/17 → 1/1/37
Project: Research project
-
Single Arm, Open-Label, Phase 2 Study of MGAH22 (Fc-optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Relapsed or Refractory Advanced Breast Cancer Whose Tumors Express HER2 at the 2+ Level by Immunohistochemistry and Lack Evidence of HER2 Gene Amplification by FISH.
Carcas, L. (PI)
1/1/13 → …
Project: Research project
-
MONALEESA-3 A randomized double-blind, placebo-controlled study of ribociclib in combination with fulvestrant for the treatment of men and postmenopausal women with hormone receptor Carcas, Page Rev. April 18, 2022 4 positive, HER2-negative, advanced breast cancer who have received no or only one line of prior endocrine treatment.
Carcas, L. (PI)
1/1/13 → …
Project: Research project
-
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer (CAPItello-291)
Carcas, L. (PI)
1/1/20 → 1/1/24
Project: Research project
-
Improved Tolerability of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer: the CONTROL Trial
Carcas, L., Barcenas, C. H., Hurvitz, P., Di Palma, J. A., Bose, R., Chien, A. J., Iannotti, N., Marx, G., Brufsky, A., Litvak, A., Ibrahim, E., Alvarez, R. H., Ruiz-Borrego, M., Chan, N., Manalo, Y., Kellum, A., Trudeau, M., Thirlwell, M., Garcia Saenz, J. & Hunt, D. & 6 others, , Sep 2020, In: Annals of Oncology. 31Research output: Contribution to journal › Article › peer-review
-
Dr. Lauren Carcas, M.D.
Carcas, L., May 2019Research output: Non-textual form › Digital or Visual Products
-
Breast Cancer Edition: A Case-based Roundtable Featuring General Oncologists presenting Actual Patient Cases to a Panel of Clinical Investigators
Carcas, L., Hurvitz, S. & Sledge, G., Aug 31 2017.Research output: Contribution to conference › Presentation
-
Dateline Health Show 451: Cancer
Carcas, L., May 16 2017Research output: Non-textual form › Digital or Visual Products
-
Interview with Lauren Carcas, M.D. regarding Hereditary Cancer and Screening Guidelines.
Carcas, L., 2017.Research output: Contribution to conference › Presentation
Activities
- 5 Membership of network
-
American Medical Association (External organization)
Carcas, L. (Member)
2000 → …Activity: Membership › Membership of network
-
Florida Society of Clinical Oncology (External organization)
Carcas, L. (Member)
2000 → …Activity: Membership › Membership of network
-
American Society of Clinical Oncology (External organization)
Carcas, L. (Member)
2000 → …Activity: Membership › Membership of network
-
American Society of Hematology (External organization)
Carcas, L. (Member)
2000 → …Activity: Membership › Membership of network
-
American College of Physicians (External organization)
Carcas, L. (Member)
2000 → …Activity: Membership › Membership of network
Prizes
-
Chief Medical Resident 2010-2011
Carcas, L. (Recipient), 2010
Prize: Prize (including medals and awards)
-
Founder’s Scholarship for Academic Achievement, Samford University 1997-2001
Carcas, L. (Recipient), 1997
Prize: Prize (including medals and awards)
-
Honor Society Memberships: Phi Alpha Theta, Pi Sigma Alpha, Sigma Delta Pi, Pi Gamma Mu, Alpha Lambda Delta
Carcas, L. (Recipient), 2024
Prize: Prize (including medals and awards)
-
Who’s Who Among Students in American Colleges and Universities, 2001
Carcas, L. (Recipient), 2001
Prize: Prize (including medals and awards)